Vitrolife

Vitrolife EBIT

The EBIT of Vitrolife (VITR.ST) as of Nov 10, 2026 is 616.00 M SEK. In the previous year, EBIT was 783.00 M SEK — a change of -21.33% (lower).

EBIT

616.00 MSEK

YoY

-21.33%

Last updated:

In 2025, Vitrolife's EBIT was 616.00 M SEK, a -21.33% increase from the 783.00 M SEK EBIT recorded in the previous year.

The Vitrolife EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2022
654.00 M SEK
Jan 1, 2023
-3.60 B SEK
Jan 1, 2024
783.00 M SEK
Jan 1, 2025
616.00 M SEK
Jan 1, 2026 (e)
799.83 M SEK
Jan 1, 2027 (e)
944.74 M SEK
Jan 1, 2028 (e)
1.05 B SEK
Jan 1, 2029 (e)
1.10 B SEK
The Vitrolife EBIT history
YEAREBITYoY
est1.10 BSEK+5.41%
est1.05 BSEK+10.87%
est944.74 MSEK+18.12%
est799.83 MSEK+29.84%
616.00 MSEK-21.33%
783.00 MSEK-121.75%
-3.60 BSEK-650.46%
654.00 MSEK+46.98%
444.96 MSEK+20.25%
370.02 MSEK-24.28%
488.69 MSEK+24.06%
393.92 MSEK+15.57%
340.86 MSEK+36.79%
249.18 MSEK+10.19%
226.14 MSEK+57.75%
143.35 MSEK+78.30%
80.40 MSEK+61.69%
49.73 MSEK+21.53%
40.92 MSEK+23.77%
33.06 MSEK+8.72%
30.41 MSEK+12.10%
27.13 MSEK+28.96%
21.03 MSEK+5.03%
20.03 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Vitrolife Revenue

Vitrolife Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
3.23 B SEK
654.00 M SEK
394.00 M SEK
Jan 1, 2023
3.51 B SEK
-3.60 B SEK
-3.85 B SEK
Jan 1, 2024
3.61 B SEK
783.00 M SEK
513.00 M SEK
Jan 1, 2025
3.44 B SEK
616.00 M SEK
-5.01 B SEK
Jan 1, 2026 (e)
3.50 B SEK
799.83 M SEK
590.36 M SEK
Jan 1, 2027 (e)
3.81 B SEK
944.74 M SEK
715.65 M SEK
Jan 1, 2028 (e)
4.06 B SEK
1.05 B SEK
812.26 M SEK
Jan 1, 2029 (e)
4.23 B SEK
1.10 B SEK
860.61 M SEK

Vitrolife Margins

Vitrolife stock margins

The Vitrolife margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Vitrolife. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Vitrolife.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2022
55.26 %
20.22 %
12.18 %
Jan 1, 2023
56.32 %
-102.51 %
-109.65 %
Jan 1, 2024
59.07 %
21.70 %
14.21 %
Jan 1, 2025
50.87 %
17.91 %
-145.73 %
Jan 1, 2026 (e)
50.87 %
22.83 %
16.85 %
Jan 1, 2027 (e)
50.87 %
24.78 %
18.77 %
Jan 1, 2028 (e)
50.87 %
25.80 %
20.01 %
Jan 1, 2029 (e)
50.87 %
26.10 %
20.34 %

Vitrolife Stock analysis

What does Vitrolife do? Vitrolife AB is a Swedish biotech company specializing in the development and marketing of products for in vitro fertilization (IVF) and regenerative medicine. It was founded in 1994 and has over 390 employees worldwide. The company's main business is IVF, offering a wide range of essential products for IVF treatment such as culture media, devices for semen analysis and preparation, embryo transfer techniques, and products for biopsy examinations and cryopreservation. Vitrolife has a presence in 110 countries and has expanded its market to China where there is a high demand for fertility treatments. The company also offers medical equipment for regenerative treatments. Vitrolife is a leading player in the IVF industry known for its high product quality and innovation. It collaborates with universities and research institutions globally to improve IVF technology and success rates. The company places importance on sustainability and environmental protection, using 100% animal-free ingredients in their culture media and practicing recycling and waste reduction in their production facilities. In summary, Vitrolife offers a wide range of products for IVF and regenerative medicine, with a focus on supporting IVF treatments. The company is a leader in its industry and actively participates in research. It is committed to sustainability and environmental responsibility. Vitrolife is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Vitrolife's EBIT

Vitrolife's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Vitrolife's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Vitrolife's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Vitrolife’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Vitrolife stock

EBIT of Vitrolife is 616.00 M SEK in 2025.

EBIT of Vitrolife changed from 783.00 M SEK to 616.00 M SEK, representing a -21.33% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Vitrolife since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Vitrolife historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Vitrolife

All Key Metrics — Vitrolife